Archive: Osteoporosis Subscribe to Osteoporosis
Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)
In 2009, the global Osteoporosis drug market was worth USD 6.8 billion, with Bisphosphonate class of drugs leading the market. In the overall Bisphosphonate, ibandronate (Bonviva/Boniva; Roche) and zoledronate (Aclasta/Zometa; Novartis) accounted...
China Osteoporosis Market Analysis and Forecast, 2007 – 2015
The Chinese Osteoporosis drug market is expected to grow at a CAGR of 14.4% from 2007 to 2015.
Increased prevalence of Osteoporosis among Chinese female population is the principal growth driver of the Osteoporosis drug market. The other key...
Global Osteoporosis Market & Drugs Analysis 2010 – 2015
Osteoporosis is often called the “”silent disease”" because bone loss occurs without symptoms. It is characterized by low bone mass and micro-architectural deterioration of bone tissue, leading to bone fragility and a consequent...
Postmenopausal Osteoporosis Therapeutics – Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released its new report, Postmenopausal Osteoporosis Therapeutics – Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the...
Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011
GlobalData’s clinical trial report, Post Menopausal Osteoporosis Global Clinical Trials Review, Q2, 2011″ provides data on the Post Menopausal Osteoporosis clinical trial scenario. This report provides elemental information and data...
Osteoporosis Global Clinical Trials Review, Q1, 2011
GlobalData’s clinical trial report, Osteoporosis Global Clinical Trials Review, Q1, 2011″ provides data on the Osteoporosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials...
Musculoskeletal Disorders Therapeutics to 2016 – Introduction of Monoclonal Antibodies with First – in – class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
GBI Research’s report, “Musculoskeletal Therapeutics to 2016 – Introduction of Monoclonal Antibodies with First-in-class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis, provides in-depth...
Osteoporosis – Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released its new report, Osteoporosis – Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global Osteoporosis therapeutics...
Womens Health Therapeutics, Analysis and Market Forecasts to 2016 – High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
GBI Researchs report, Women’s Health Therapeutics Market to 2016 – High Unmet Need will Drive the Uptake of Novel Drugs in Menopause and Osteoporosis, provides in-depth analysis of unmet needs, drivers and barriers that impact the...